Strunge P, Frandsen J, Andreasen F
Medical Department, Horsens Sygehus, Denmark.
Eur Heart J. 1988 Jan;9(1):106-9.
A case study is presented in which amiodarone (A) was given during the whole of pregnancy and during the breast feeding period. An intensive observation of thyroid tests, serum concentrations of A and its metabolite, desethylamiodarone (DEA) was undertaken. The child was observed in the same way from birth until 2 months of age. The milk was analyzed for A and DEA. As reported in other published cases, transplacental passage was found and there was a relatively high concentration of amiodarone in the milk. Our child like the other children was healthy at birth, being euthyroid and with no goiter or corneal deposits. No effect was observed of the medication on growth, thyroid tests or cornea. It is concluded that amiodarone can be given during pregnancy but it is advisable to use as low doses as possible and control the serum concentrations at regular intervals. Breast feeding need not be forbidden.
本文呈现了一个病例研究,其中在整个孕期及哺乳期均给予了胺碘酮(A)。对甲状腺检查、A及其代谢产物去乙基胺碘酮(DEA)的血清浓度进行了密切观察。从出生到2个月大,以同样的方式对该儿童进行了观察。对乳汁进行了A和DEA分析。正如其他已发表病例所报道的,发现了经胎盘转运,且乳汁中胺碘酮浓度相对较高。我们的孩子和其他孩子一样,出生时健康,甲状腺功能正常,无甲状腺肿或角膜沉着。未观察到该药物对生长、甲状腺检查或角膜有影响。结论是孕期可以使用胺碘酮,但建议尽可能使用低剂量,并定期监测血清浓度。母乳喂养无需禁止。